In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Pollution and winter linked with rise in heart attack treatment

Interventional Cardiology and Cardiovascular Surgery
Preventive Cardiology
Environmental and Occupational Aspects of Heart Disease


Paris, France – 23 Aug 2019: Heavily polluted areas have a higher rate of angioplasty procedures to treat blocked arteries than areas with clean air, according to research to be presented at ESC Congress 2019 together with the World Congress of Cardiology. (1) Procedures are even more common in winter, the most polluted time of year.

Study author Dr Rafal Januszek of the University Hospital in Krakow, Poland said: “Epidemiological studies have reported negative impacts of pollution on the cardiovascular system but the effects on specific diseases were unclear. We also show for the first time that patients from areas with cleaner air are more sensitive to changes in pollution, while those from more polluted cities can adapt to fluctuations.”

Using particulate matter (PM) 10 levels published by the Chief Inspectorate for Environmental Protection in Poland, six unpolluted cities and five polluted cities were selected for the study. PM10 are particles ten micrometres or less in diameter. Sources include industrial processes like iron making and quarrying, lawn mowing, wood and coal stoves, bushfires, dust storms, and vehicle exhaust emissions.

The study enrolled 5,648 patients from unpolluted cities and 10,239 patients from polluted cities. All patients underwent stent insertion (percutaneous coronary intervention; PCI) to open arteries blocked due to acute coronary syndromes (heart attack or unstable angina). PCI data were obtained from the ORPKI Polish National PCI Registry.

Dates of PCI procedures were matched with air quality on the same day during a 52-week period. Analyses were also performed to compare winter versus non-winter weeks because pollution levels rise during winter.

The annual average PM10 concentration was significantly higher in polluted cities (50.95 µg/m3) compared to unpolluted cities (26.62 µg/m3). In both polluted and unpolluted areas, a rise in PM10 concentration was significantly associated with a greater frequency of PCI.

Patients in cities with clean air were more sensitive to pollution rises, with each 1 µg/m3 increase in PM10 concentration linked to 0.22 additional PCIs per week. While in polluted cities, the same rise in PM10 was linked with just 0.18 additional PCIs per week.

Regarding the seasonal effect, the PCI rate was significantly lower in non-winter, compared to winter, weeks in both polluted and clean cities. “The higher incidence of PCI in winter is related to greater air pollution during this period,” said Dr Januszek. “This is due to several factors such as artificial heating and the resulting smog.”

He concluded: “The study shows that the incidence of acute coronary syndromes treated with PCI was higher in winter and rose along with increasing pollution, and this rise was higher in regions with initially cleaner air, if taking the same increment in pollution into account. This is further evidence that more needs to be done to lower pollution levels and protect the public’s health.”

ENDS

Notes to editor

Notes to editors

Authors: ESC Press Office 
Mobile: +33 (0) 7 8531 2036
Email: press@escardio.org

Follow us on Twitter @ESCardioNews 

The hashtag for ESC Congress 2019 together with the World Congress of Cardiology is #ESCCongress

Funding: None.

Disclosures: None.

References and notes

(1) The abstract “Increased air pollution expressed as PM10 concentration and winter time are related to the frequency of percutaneous coronary interventions in patients with acute coronary syndromes” will be presented during Poster Session 4: Clinical epidemiology and prevention on Monday 2 September at 08:30 to 12:30 CEST in the Poster Area.

About ESC Congress

ESC Congress is the world’s largest gathering of cardiovascular professionals contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2019 together with the World Congress of Cardiology takes place from 31 August to 4 September at the Expo Porte de Versailles in Paris, France. Explore the scientific programme.

About the European Society of Cardiology 

The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

This press release accompanies a presentation at ESC Congress 2019 together with the World Congress of Cardiology. It does not necessarily reflect the opinion of the European Society of Cardiology.